Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CASKIN1 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | NPSR1 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | HLX | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | RABAC1 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | IFI30 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | CCDC88B | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-05 |
mRNA | TSNAX-DISC1 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | FTHL17 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | PAOX | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | CNOT6 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |